Period1 mediates rhythmic metabolism of toxins by interacting with CYP2E1

Wenhao Ge1, Tao Wang2, Yang Zhao1

  • 1Center for Molecular Metabolism, Nanjing University of Science & Technology, Nanjing, China.

Cell Death & Disease
|January 13, 2021
PubMed

Insights

The clock gene Per1 elevates with toxin exposure. Lacking Per1 slows toxin metabolism and reduces liver injury, suggesting Per1

Area of Science:

  • Chronobiology
  • Hepatology
  • Toxicology

Background:

  • Circadian rhythms regulate liver metabolic functions, including detoxification.
  • The precise role of clock genes in responding to and influencing toxin metabolism and toxicity remains largely unknown.

Purpose of the Study:

  • To investigate the role of the clock gene Per1 in the liver's response to toxins.
  • To elucidate the molecular mechanisms by which Per1 influences toxin metabolism and hepatotoxicity.

Main Methods:

  • Utilized a mouse model with Per1 deficiency (Per1-knockout mice).
  • Administered toxins such as carbon tetrachloride (CCl4), capsaicin, and acetaminophen to wild-type and Per1-deficient mice.
  • Analyzed plasma toxin residues, liver injury markers, fibrosis, and gene/protein expression (PER1, HNF-1α, Cyp2e1).

Main Results:

  • Per1 expression was specifically elevated in mice exposed to toxins like CCl4.
  • Per1-deficient mice exhibited slower metabolism of CCl4, capsaicin, and acetaminophen, with higher plasma toxin levels.
  • Liver injury and fibrosis induced by CCl4 were significantly reduced in Per1-deficient mice.
  • PER1 protein binds to HNF-1α, enhancing its recruitment to the Cyp2e1 promoter and increasing Cyp2e1 expression, which promotes toxin metabolism.

Conclusions:

  • The clock gene Per1 plays a crucial role in mediating the metabolism of various toxins in the liver.
  • Per1 deficiency protects against toxin-induced liver injury and fibrosis by modulating toxin metabolism.
  • Targeting Per1 response presents a potential therapeutic strategy for mitigating toxin-induced hepatotoxicity.

Related Concept Videos

Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.2K
Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.3K
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
4.2K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
18.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
17.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89